Akorn (AKRX) to Acquire Minority Stake in Aciex Therapeutics
Tweet
Share
E-mailGet Alerts AKRX Hot Sheet
Join SI Premium – FREE
Akorn, Inc. (Nasdaq: AKRX), has entered an agreement to acquire a minority ownership in Westborough, MA, based Aciex Therapeutics Inc.
In addition, Akorn signed a global licensing agreement for a novel over-the-counter eye care product and manufacturing agreement for one of Aciex’s lead prescription products.
Financial terms of the deal were not disclosed.
In addition, Akorn signed a global licensing agreement for a novel over-the-counter eye care product and manufacturing agreement for one of Aciex’s lead prescription products.
Financial terms of the deal were not disclosed.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bernstein on whether Hershey (HSY) could eventually step up to buy Mondelez (MDLZ)
- Questor Technology signs LOI to acquire Emission Rx for up to C$3M
- Bunker Hill Mining to acquire Silver47 in all-share merger deal
Create E-mail Alert Related Categories
Mergers and AcquisitionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
